Feds target joint docs in kickbacks probe

Share this article:
Federal investigators are zeroing in on individual hip and knee surgeons in an investigation into kickbacks to doctors by orthopedic device manufacturers, The New York Times reports.

US attorney for the district of New Jersey Christopher Christie recently addressed the sales meetings of five companies, the Times said, quoting a Stryker executive as saying Christie told them “I've dealt with the supply issue, now I need to deal with the demand issue.”

Four companies – Biomet, Johnson & Johnson's DePuy Orthopaedics, Smith & Nephew and Zimmer Holdings – agreed to pay a combined total of $310 million to settle civil charges related to the inquest in September. Stryker was included in that settlement but did not pay a fine, as it was the first to cooperate in the investigation. All entered corporate integrity agreements.

The firms were accused of paying kickbacks to doctors in the form of consulting fees in exchange for recommending their products to patients.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in News

New lipid agents are high on potency, low on doc awareness

New lipid agents are high on potency, low ...

The new PCSK9 class of cholesterol-lowering antibodies continues to look promising, but many doctors—particularly PCPs—have never even heard of the experimental drugs.

Novartis may have game-changing drug

Novartis may have game-changing drug

Key opinion leaders indicate they are ready to embrace Novartis's experimental heart failure medication LCZ696. Such a move could upend heart failure treatment protocols.

Five things for pharma marketers to know: Tuesday, September 2

Five things for pharma marketers to know: Tuesday, ...

Sanofi and Regeneron unveil Phase-III results of their PCSK9; Merck will present data on its anti-PD-1 at the end of this month; WSJ op/ed suggests US should lead fight against ...